American Association for Cancer Research
15417786mcr110419-sup-f3_43k.pdf (43.86 kB)

Supplementary Figure 3 from Migfilin Regulates Esophageal Cancer Cell Motility through Promoting GSK-3β–Mediated Degradation of β-Catenin

Download (43.86 kB)
journal contribution
posted on 2023-04-03, 17:43 authored by Huan He, Fang Ding, Yi Li, Aiping Luo, Hongyan Chen, Chuanyue Wu, Zhihua Liu

PDF file - 43K



Migfilin, a protein component of focal adhesions, has been implicated in regulation of cell–extracellular matrix adhesion and motility but the underlying mechanisms are not fully elucidated. In this study, we have determined the functions of migfilin in esophageal cancer cells and the mechanisms involved. We show that the expression level of migfilin is negatively associated with clinical metastasis, and enforced expression of migfilin suppressed cell motility through decreased free β-catenin level. Overexpression of migfilin resulted in destabilization of β-catenin in concomitance with reduction of its transcriptional activity. Knockdown of migfilin by siRNA, transfection of a mutant β-catenin at Ser37 which is a critical phosphorylation site of GSK-3β, GSK-3β inhibitor LiCl, or proteasome inhibitor MG132 reversed the migfilin-mediated β-catenin degradation and transcription inhibition. Moreover, migfilin promoted β-catenin degradation by reinforcing the association between β-catenin and GSK-3β. In addition, exogenously expressed β-catenin partially restored migfilin-induced suppression of cell invasion. Collectively, these results suggest that the expression level of migfilin in ESCCs is inversely correlated with clinical metastasis status, and migfilin inhibits ESCC cell invasion at least in part through promoting degradation of β-catenin. Mol Cancer Res; 10(3); 273–81. ©2012 AACR.

Usage metrics

    Molecular Cancer Research



    Ref. manager